Friday, December 14, 2007

Stong Words on Dendreon vs. FDA

I agree with his feelings on Dendreon 100%.
For the sake of prostate cancer patients, of whom we lose some 30,000
each year, here’s to hoping the decision to approve comes earlier rather
than later. Provenge is safe and effective even if the biostatistics are not
as perfect as some FDA bureaucrats and their enablers in the ivory towers of
academia would like. Last I checked, our society ranks saving lives well
ahead of bureaucratic perfection on our list of priorities. With some luck,
Congressional hearings might remind the FDA of this fact.

If it is safe and it is actually saving some lives then why hasn't it been approved? Late stage prostate cancer victims are dying while waiting for the FDA. Let's hope those Congressmen can get the FDA to budge on this thing.

No comments: